GGrantIndex
← Leaderboards

Timothy Daniel O'Connell

University Of South Dakota

$4,473,187
Attributed
$6,933,269
Total exposure
12
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $711.2K · FY200524
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$6,933,269 · 12

By mechanism

R01$4,920,165 · 2
P20$2,013,104 · 10

Top collaborators

Most similar at University Of South Dakota

Same institution · by research overlap

Others in their field

Top investigators on “Cardiac Myocytes

Research focus

Cardiac MyocytesMuscle CellsMediatingFunctional DisorderCardiacHeartPathologicHeart FailurePreventAdultSignal TransductionReceptorReportingFundingCoronary Heart DiseaseG-Protein-Coupled ReceptorsFibrosisGrantInterstitialCell DeathCardiovascular DiseasesEicosapentaenoic AcidFatty AcidsHypoxia

Grant awards (19)

Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$665,482
R01 · FY2024 · HL · contact PI
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$679,062
R01 · FY2023 · HL · contact PI
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$679,062
R01 · FY2022 · HL · contact PI
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$678,416
R01 · FY2021 · HL · contact PI
Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injury$711,176
R01 · FY2020 · HL · contact PI
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$374,874
R01 · FY2019 · HL · contact PI
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$374,874
R01 · FY2018 · HL · contact PI
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$373,031
R01 · FY2017 · HL · contact PI
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction$384,188
R01 · FY2016 · HL · contact PI
A1-ADRENERGIC RECEPTORS PREVENT PATHOLOGIC VENTRICULAR REMODELING FOLLOWING MI$336,137
P20 · FY2011 · RR · contact PI
SD COBRE: CELL CULTURE CORE$204,965
P20 · FY2011 · RR · contact PI
A1-ADRENERGIC RECEPTORS PREVENT PATHOLOGIC VENTRICULAR REMODELING FOLLOWING MI$320,685
P20 · FY2010 · RR · contact PI
SD COBRE: CELL CULTURE CORE$192,888
P20 · FY2010 · RR · contact PI
A1-ADRENERGIC RECEPTORS PREVENT PATHOLOGIC VENTRICULAR REMODELING FOLLOWING MI$327,445
P20 · FY2009 · RR · contact PI
SD COBRE: CELL CULTURE CORE$189,909
P20 · FY2009 · RR · contact PI
SD COBRE: CELL CULTURE CORE$188,785
P20 · FY2008 · RR · contact PI
ALPHA1-AR LOCALIZATION IN CARDIAC MYOCYTES$2,309
P20 · FY2007 · RR · contact PI
SD COBRE: CELL CULTURE CORE$171,260
P20 · FY2006 · RR · contact PI
SD COBRE: CELL CULTURE CORE$78,721
P20 · FY2005 · RR